ClinicalTrials.gg
WithdrawnNCT03860324ESFIBHAUpdated Aug 27, 2021

Erector Spinae vs Fascia Iliaca Block in Hip Arthroplasty

An interventional study of Single-shot erector spinae plane block and Single-shot fascia iliaca block in Pain, Postoperative, sponsored by Hospital Beatriz Ângelo. Withdrawn at 1 site in Portugal. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2021-08-27.

Sponsored by Hospital Beatriz Ângelo · Not applicable, Interventional, and Prevention

How we know

Why this study was withdrawn
Cancelled

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 12 studies in Pain, Postoperative with a site in Portugal — 2 open to participants now, 2 under way, none of them phase 3. Pain, Postoperative · Portugal.

Enrollment
10th of 10
0 · median 60
Started
2019
with 2 others
No phase
5 of 12
none open now
Registered
7th of 12
by date
Lead sponsor
1 of 12
Hospital Beatriz Ângelo

Among the 12 studies in Pain, Postoperative with a site in Portugal, this one is the 10th largest by enrollment of the 10 interventional ones that give a count, is one of 3 that started in 2019, is one of 5 with no phase, and was the 7th registered.

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

Browse Pain, Postoperative studies →

Open to participants now

2 of the 12 studies in Pain, Postoperative with a site in Portugal are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 678 Pain, Postoperative studies recruiting now, 239 (35%) set no upper age limit and 329 (49%) stop at 75 or younger; 74 take children under 18; 129 take healthy volunteers.

This study: 18 Years and older · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 12 studies in Pain, Postoperative with a site in Portugal, or all of them as a file.
02

Study summary

The thoracic erector spinae plane (ESP) block was first described by Forero et al in September 2016. In their article, the authors presented the possibility of using this block as an option for the control of thoracic neuropathic pain as well as post-operative thoracic pain. The ESP block is done by administering local anesthetic in the plane deep to the erector spinae muscle, which spreads through the costotransverse foramen to the dorsal and ventral roots of the spinal nerves.

Since then, there have been reports about the successful use of this block for bariatric surgery, ventral hernia repair, radical mastectomy, rib fractures, major abdominal surgery and hip replacement. However, there are no studies in the literature comparing the efficacy of the ESP block to other nerve blocks.

The purpose of this study is to compare the post-operative analgesic efficacy of the ESP block to the fascia iliaca (FI) block after total hip replacement (THR).

03

Conditions studied

  • Pain, Postoperative

Browse trials for

Keywords

  • Hip Arthroplasty
  • Erector Spinae Plane Block
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Surgical plan for total hip replacement
  • Signing of consent form to participate in the study

Exclusion criteria

Exclusion Criteria:

  • Patient refusal
  • > 40 kg/m2
  • Surgical plan for revision of hip replacement
  • Patient unable to quantify pain level
  • Chronic kidney disease with a \< 50ml/min
  • Previously medicated with opioids
  • Patient unable to perform the surgery with spinal block
  • Allergy to local anesthetics
  • Infection in the site of the Erector Spinae Plane or Fascia Iliaca block
  • Allergy or to the use of morphine
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

GFR and eGFR (kidney filtering)

GFR (glomerular filtration rate) is how much blood the kidneys filter each minute. It is usually estimated from a blood test — eGFR, by formulas such as CKD-EPI or MDRD — and some studies ask for it to be measured directly instead. Usually given in mL/min/1.73 m².

Check the method, the units and the minimum the study states. A value of 90 or above is in the normal-or-high range, but kidney damage can show in other tests too.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
0 participants (actual)

Study arms

  • No intervention
    Control-group

    No peripheral nerve block

  • Experimental
    Single-shot erector spinae plane block

    The patient is positioned in lateral decubitus. The anesthesiologist uses a linear high-frequency probe in a longitudinal direction laterally to the mid-sagittal plane at the level of L4 until the transverse process is identified and, more superficial, the erector spinae muscle. A 22G needle of 80mm is introduced in-plane craniocaudally towards the transverse process of L4 until its tip is in the plane deep to the erector spinae muscle. Single-shot block with 30ml of ropivacaine 0,5% + adrenaline 100mcg

    Procedure: Single-shot erector spinae plane block

  • Active comparator
    Single-shot fascia iliaca block

    The patient is positioned in dorsal decubitus. The anesthesiologist uses a linear high-frequency probe in a transversal direction, below the crural arch so as to identify the femoral artery. Afterwards the probe is moved laterally to find the iliac muscle and its fascia. A 22G needle of 80mm is introduced in-plane latero-medially until its tip is below the fascia iliaca (between the muscle and its fascia). Single-shot block with 40ml of ropivacaine 0,2%.

    Procedure: Single-shot fascia iliaca block

Interventions

  • ProcedureSingle-shot erector spinae plane block

    Single-shot Erector Spinae Plane block with 30ml of ropivacaine 0,5% + adrenaline 150mcg.

  • ProcedureSingle-shot fascia iliaca block

    Single-shot Fascia Iliaca block with 40ml of ropivacaine 0,2%

06

What researchers measure

Primary outcomes

  1. Post-operative pain level measured by the Visual Analog Scale

    Measurement of patient's pain level using the Visual Analog Scale (with a score of 0-100, 0 being no pain and 100 maximum pain)

    Time frame: At 6 hours post-operative

  2. Post-operative pain level measured by the Visual Analog Scale

    Measurement of patient's pain level using the Visual Analog Scale (with a score of 0-100, 0 being no pain and 100 maximum pain)

    Time frame: At 12 hours post-operative

  3. Post-operative pain level measured by the Visual Analog Scale

    Measurement of patient's pain level using the Visual Analog Scale (with a score of 0-100, 0 being no pain and 100 maximum pain)

    Time frame: At 24 hours post-operative

  4. Post-operative pain level measured by morphine consumption using patient-controlled intravenous analgesia

    Total amount (in mg) of morphine administered by a patient-controlled intravenous analgesia pump of morphine 1mg/ml with bolus of 1ml per patient request with a lockout time of 10 minutes

    Time frame: At 24 hours post-operative

Secondary outcomes

  1. Muscle Strength grade

    Muscle strength grade and comparison with the contralateral limb in the quadriceps femoris muscle Muscle strength scale: Grade 0: No muscle contraction is detected Grade 1: Muscle contraction is identified but it is insufficient to produce motion Grade 2: The muscle can move the joint only if the force of gravity is eliminated Grade 3: The muscle can move the joint against gravity but without any resistance Grade 4: The muscle can move the joint against moderate resistance Grade 5: The muscle can move the joint against full resistance

    Time frame: At 12 hours post-operative

  2. Muscle Strength grade

    Muscle strength grade and comparison with the contralateral limb in the quadriceps femoris muscle Muscle strength scale: Grade 0: No muscle contraction is detected Grade 1: Muscle contraction is identified but it is insufficient to produce motion Grade 2: The muscle can move the joint only if the force of gravity is eliminated Grade 3: The muscle can move the joint against gravity but without any resistance Grade 4: The muscle can move the joint against moderate resistance Grade 5: The muscle can move the joint against full resistance

    Time frame: At 24 hours post-operative

  3. Sensory block assessed through a temperature test

    Assessment of sensory block through a temperature test and comparison with the contralateral limb (sensory block vs no sensory block)

    Time frame: At 24 hours post-operative

  4. Sensory block assessed through a tactile stimulation test

    Assessment of sensory block through a tactile stimulation test and comparison with the contralateral limb (sensory block vs no sensory block)

    Time frame: At 24 hours post-operative

  5. Detection of side effects related to the anesthetic and analgesic technique namely pruritus, urinary retention, nausea and vomiting in each patient

    Presence of side effects (pruritus, urinary retention, nausea/vomiting)

    Time frame: At 24 hours post-operative

07

Study locations

1 site
  • Hospital Beatriz Ângelo
    Loures, Lisboa 2674-514, Portugal
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Apr 2019; primary completion for Jun 2019, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 24, 2019
First posted
Mar 1, 2019
StartEst.
Apr 1, 2019
Primary completionEst.
Jun 30, 2019
CompletionEst.
Dec 31, 2019
Last update
Aug 27, 2021
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 27, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT03860324
Lead sponsor
Hospital Beatriz Ângelo
Responsible party
André Carrão (Principal Investigator, Hospital Beatriz Ângelo) — Principal investigator
First posted
Mar 1, 2019
Start date
Apr 1, 2019 (estimated)
Primary completion
Jun 30, 2019 (estimated)
Completion
Dec 31, 2019 (estimated)
Last update
Aug 27, 2021

Study contacts

André Carrão
principal investigator · Hospital Beatriz Ângelo

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Aug 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion